Comparative In vivo Evaluation of Aripiprazole Coprecipitate, Nanoparticles and Marketed Tablets in Healthy Human Volunteers and In vitro-In vivo Correlation

Order of Publishing in Issue: 
3
Volume :5
Issue :4
October, 2011
Page No: 
1397-1409
Authors: 
Aly A. Abdelbary [1], Ahmed H. Elshafeey [2, 3], Mohamed El-Nabarawi [2], Abdelhalim Elassasy [2], Xiaoling Li [1] and Bhaskara Jasti [1]*
Address: 
[1] Thomas J. Long School of Pharmacy & Health Sciences, University of the Paciûc 3601 Paciûc Avenue, Stockton, CA 95211, United States
Address: 
[2] Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo 11562, Egypt
Address: 
[3] Genuine Research Center, Cairo, Egypt
Email-ID: 
bjasti@pacific.edu

Abstract

The aim of this study was to evaluate the bioavailability of two aripiprazole tablets, coprecipitate (CP) and nanoparticles (NP) when compared to the market tablets. A single-dose, randomized, three period crossover design under fasting conditions in healthy human volunteers was studied. The dissolution rate of the CP, NP and market tablets was determined. In order to investigate the feasibility of in vitro data as a tool for predicting in vivo results, two types of in vitro-in vivo correlation (IVIVC), level C and multiple level C, were studied. Almost 75% of aripiprazole was dissolved from the nanoparticles tablets within 10 minutes compared with 20% and 46% for coprecipitate and market tablets, respectively. The mean AUC0-72 value of aripiprazole from the NP tablets (6136.35 ± 421.29 ng.hr/mL) was significantly higher than both CP tablets (3216.12 ± 525.02 ng.hr/mL) and market tablets (5215.57 ± 457.28 ng.hr/mL) (p d” 0.05). The relative bioavailability of aripiprazole after oral administration of the CP and NP tablets was 61.66% and 117.65%, respectively. The higher dissolution rate of NP tablets resulted in rapid absorption of aripiprazole and consequently higher bioavailability. Multiple level C IVIVC showed the bioequivalence of NP and bioinequivalence of the CP tablets in comparison to market tablets.

Keywords: 
Aripiprazole; Coprecipitate; Nanoparticles; Bioequivalence; Volunteers.
AttachmentSize
Paper-3.pdf167.02 KB

 
To download full text articles and issues in PDF at no cost.All you have to do is fill out a brief registration form. It's easy and it's free. At any time, you may request removal of your contact information from our database.
Click here to Register | Click here if you have already registered

2018 ABAP Awards

Invitation for Nominations to 2019 ABAP Awards
The Association of Biotechnology and Pharmacy invites nominations for the following awards from the eligible talented people with proven track record and achievements on or before August 31, 2019 in the prescribed format.

DOWNLOAD CIRCULAR | APPLICATION FORM

AWARDS

User login